Screener
Kamada
KMDAKamada is a drug manufacturers - specialty & generic company in the healthcare sector trading on NASDAQ, led by CEO Amir London, with a market cap of $417.1M.
$417.13M+3.5%
We’re still putting together Kamada’s detailed financials. Its latest earnings are below. You’ll find its full filings on SEC EDGAR, or explore the companies we cover.
Ask us to move Kamada up the queue, and we’ll analyze its filings next.
Earnings
Next report
Aug 12, 2026 (In 1 week)Revenue estimate$50.8M
EPS estimate$0.12
Profile
CountryIsrael
Listed2013
Employees378.0
CEOAmir London
SectorHealthcare
Websitekamada.com
FilingsSEC EDGAR